House Commerce Committee expected to mark up FDA reform legislation by mid-July.
This article was originally published in The Gray Sheet
Executive Summary
HOUSE COMMERCE FDA REFORM LEGISLATION EXPECTED TO BE MARKED UP BY MID-JULY, with the goal of securing passage by the House and completing conference negotiations with the Senate before Congress' August recess begins on Aug. 2. Sen. James Jeffords' (R-Vt.) FDA reform legislation was reported out of the Labor and Human Resources Committee June 18 ("The Gray Sheet" June 23, p. 8).
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.